Charting the S&P 500: New Highs, But Was It Convincing Enough?
The S&P joined the Nasdaq in printing a new high this past week, but can it continue?
The S&P joined the Nasdaq in printing a new high this past week, but can it continue?
Sentiment slips to just 1.5 points above its all-time low with current conditions at a record while inflation expectations rise.
Let’s check out two biopharma plays that scream ‘growth at a reasonable price.’
Advanced Micro Devices’ high expectations are justified by the chipmaker’s phenomenal growth.
Waller’s rate-hike warning, PepsiCo’s outlook cut and TSMC’s 54% surge.
Multiyear future contracted bookings mean using PEG ratio valuation, not a simple P/E metric.
The stock is back in familiar territory, where dip buyers got very aggressive. Here’s what to watch now.
Your AI will call their AI. Here’s the stock I’m buying for that.
An average of initial claims fell to its lowest since September 2022 and one for continuing claims fell to its lowest since April 2023.
There are two major risks that investors seem more than happy to underweigh.